Chitinor AS Reaches Agreement with BASF

Chitinor AS has reached an agreement with BASF SE to acquire BASFs marine biopolymers chitosan business operations. The deal marks a strategic milestone for Chitinor’s business development plans for expanding its biopolymer product ranges and business-to-business operations.

Under the agreement Chitinor will acquire production facilities in Tromsø, Norway, inventories, patents, Chitopharm™ trademark, product and application technologies, and global customer portfolio for all chitosan product ranges, including functional cosmetic ingredients and Chitopharm™ pharmaceutical ingredients with corresponding Drug Master Files. The transaction is expected to be formally completed by August, 2012.

“With the acquisition of BASFs chitosan business operations, we are significantly strengthening our product and customer portfolio for our marine biopolymer business area. The inclusion of BASFs production facilities in Tromsø is a strategic and synergistic fit to our existing biopolymer operations in Troms, Northern Norway,” says Thorleif Thormodsen, CEO of Seagarden ASA and Chairman of the Board of Seagarden ASAs fully owned daughter company Chitinor AS. “The combination of BASFs proprietary technology for tailored manufacture of high quality chitosans for cosmetic and pharmaceutical uses and Chitinor’s track-record and know-how related to chitin based biopolymers will provide our customers with a strong supply-chain for top quality products unmatched by anyone. Importantly, the acquisition also represents a valuable addition to our customer portfolio in the cosmetic and pharmaceutical markets,” adds Bjarte Langhelle, Commercial Director of Seagarden ASA.

About Chitinor AS
Chitinor AS is a leading producer and supplier of marine biopolymers based on shells from North-Atlantic cold-water shrimp, Pandalus borealis. By direct and full integration with Norway’s largest shrimp processor, the company relies on minute-fresh and fully traceable raw materials for production of high quality marine biopolymers supplied to the international food and pharmaceutical markets. Chitinor AS is a fully owned subsidiary of Seagarden ASA, Haugesund, Norway.

About Seagarden ASA
Seagarden ASA is a Norwegian Public Company with around 80 shareholders. The company is registered in Haugesund, Norway, and is the holding company for Seagarden AS, Chitinor AS, Atlantic Ingredients AS, Arctic Medical Nutrition AS and Avaldsnes Property AS.

Associated companies:


Related news

Latest news

UiB and CMR in high-tech collaboration

Students from UiB last month joined an experiment with an ultra-high-speed camera. This was a part of the troubleshooting of the Field Kelvin Probe currently under development.

Hatteland Display at International Workboat Show 2016

Hatteland Display are highlighting its diverse portfolio of maritime displays and panel computers on its booth (#1658) at the International Workboat Show 2016 (IWBS 2016) this week.

Servogear Announces Upcoming Events

Servogear announces a busy end of November, beginning of December. They will be participating at important international exhibitions.

Teamtec and ANDRITZ Cooperation

ANDRITZ and TeamTec have signed a cooperation agreement for worldwide marketing of the SeaSOx exhaust gas cleaning system for the maritime industry. 

Export Credit Norway looking for Norway's Best Exporter

Export Credit Norway  has now opened the nomination process for the 2017 Export Award, searching the Norwegian exporter of the year. 

Global Economic Outlook

7 December, Oslo Chamber of Commerce invites to a session with insightful updates on the Norwegian and international economy.

Rebuilding for Hydrogen

M/Y “Che Guevara”, previously owned by Gaddafi, will be converted to run on hydrogen. Greenstat will lead the project and are seeking partners.

Scana training at Servogear

In week 43-45 Servogear  had the pleasure of having Mr. Sun Xiaojia and Mr. Tzuu Kin Tan from Scana staying in the Servogear hometown of Rubbestadneset.

Quality and Customer Satisfaction

Cost efficiency is important. But we can’t rely on cost-cutting alone. At Beerenberg we have asked ourselves the following question: What does it take for the market to continue to choose providers such as Beerenberg in th...